BMY gears up for Q2 results as growth drugs partially offset legacy declines, cost cuts kick in and new launches gain ...

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be reporting results this Thursday morning. Here’s what you ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the top low volatility healthcare stocks to buy now. On July 24, Goldman ...

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Best and Safe Dividend Stocks to Buy Now. Bristol-Myers ...

The first half of 2025 has been topsy-turvy for Bristol Myers BMY. Shares of this biotech giant have lost 16.3% year to date compared with the industry ’s decline of 2.7%. The stock has also ...

Inflation Shock (2022) BMY stock declined 40.2% from a high of $81.13 on 2 December 2022 to $48.48 on 21 November 2023, compared to a peak-to-trough drop of 25.4% for the S&P 500 ...

PFE and BMY’s attractive dividend yield is a strong positive for investors. However, PFE’s dividend yield of 7.2% is higher than BMY’s 5.29%. Which Stock Is a Better Pick for Now?

When we consider that BMY is beating estimates most of the time, rounding this up to $50 seems reasonable -- at $59 per share, you can thus essentially buy all of BMY's profits from 2027 onwards ...

Bristol Myers Squibb Co. closed 26.69% short of its 52-week high of $63.33, which the company achieved on March 11th.

Bristol Myers Squibb stock (NYSE: BMY) has risen by 7% this year, outperforming the S&P 500 which has fallen by 1%. BMS’s robust Q4 performance has contributed to its positive momentum. Although ...